Skip to main content
Back
Watch Compare

ENvue Medical, Inc.

Data quality: 100%
FEED
Nasdaq Manufacturing Measuring & Analyzing Instruments
$1.75
▼ $0.09 (-4.89%)
Mkt Cap: 1.90 M
Price
$1.75
Mkt Cap
1.90 M
Day Range
$1.68 — $1.81
52-Week Range
$0.99 — $88.20
Volume
133,428
Open $1.80
50D / 200D Avg
$2.22
21.26% below
50D / 200D Avg
$4.98
64.87% below

Quick Summary

Key Takeaways

Revenue grew 42.35% annually over 5 years — strong growth
Negative free cash flow of -7.28 M
Revenue growth is decelerating — 1Y growth trails 5Y average by 30.30%
Capital efficient — spends only 1.38% of revenue on capex

Growth

Revenue Growth (5Y)
42.35%
Above sector avg (1.82%)
Revenue (1Y)12.05%
Earnings (1Y)N/A
FCF Growth (3Y)N/A

Quality

Return on Equity
-16.31%
Above sector avg (-53.47%)
ROIC-17.02%
Net Margin-251.92%
Op. Margin-351.77%

Safety

Debt / Equity
N/A
Current Ratio0.86
Interest Coverage-33.26

Valuation

PE (TTM)
-0.28
Above sector avg (-1.47)
P/B Ratio0.04
EV/EBITDAN/A
Dividend YieldN/A

Price History

Financial Trends

Peer Comparison

vs Manufacturing sector median (1364 peers)
Metric Stock Sector Median
P/E -0.3 -1.5
P/B 0.0 1.6
ROE % -16.3 -53.5
Net Margin % -251.9 -41.5
Rev Growth 5Y % 42.4 1.8
D/E — 0.3

All Fundamental Metrics
Growth
Revenue Growth (1Y) 12.05% Revenue Growth (3Y) 84.43%
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) 42.35% Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) 2.69 M Net Income (TTM) -6.76 M
ROE -16.31% ROA -12.78%
Gross Margin 30.02% Operating Margin -351.77%
Net Margin -251.92% Free Cash Flow (TTM) -7.28 M
ROIC -17.02% FCF Growth (3Y) N/A
Safety
Debt / Equity N/A Current Ratio 0.86
Interest Coverage -33.26 Asset Turnover 0.05
Working Capital -1.63 M Tangible Book Value -1.44 M
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio -0.28 Forward P/E N/A
P/B Ratio 0.04 P/S Ratio 0.71
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield -382.34%
Market Cap 1.90 M Enterprise Value -5.05 M
Per Share
EPS (Diluted TTM) -19.58 Revenue / Share 2.47
FCF / Share -6.69 OCF / Share -6.66
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue 1.38% FCF Conversion 107.64%
SBC-Adj. FCF -7.50 M Growth Momentum -30.30

Income Statement

Annual, most recent first
Metric FY2024 FY2023 FY2022 FY2021 FY2020
Revenue 2.56 M 2.28 M 752,000.0 1.70 M 623,000.0
Net Income -3.71 M -3.71 M -5.45 M -14.28 M -4.33 M
EPS (Diluted) -13.73 -2.12 — — —
Gross Profit 1.51 M 1.54 M 167,000.0 770,000.0 214,000.0
Operating Income -3.58 M -3.44 M -5.01 M -5.68 M -4.72 M
EBITDA — — — — —
R&D Expenses 909,000.0 185,000.0 283,000.0 293,000.0 171,000.0
SG&A Expenses — — — — —
D&A 1,000.0 1,000.0 1,000.0 2,000.0 2,000.0
Interest Expense 135,000.0 135,000.0 347,000.0 147,000.0 147,000.0
Income Tax 19,000.0 29,000.0 35,000.0 32,000.0 15,000.0

Balance Sheet

Annual, most recent first
Metric FY2024 FY2023 FY2022 FY2021 FY2020
Total Assets 3.63 M 6.67 M 5.88 M 8.62 M 8.23 M
Total Liabilities 3.00 M 2.69 M 2.65 M 2.31 M 5.84 M
Shareholders' Equity 627,000.0 3.99 M 3.23 M 6.31 M 2.39 M
Total Debt — — — — —
Cash & Equivalents — — — 7.74 M 7.14 M
Current Assets 3.33 M 6.49 M 5.61 M 8.34 M 7.97 M
Current Liabilities 2.72 M 2.45 M 2.32 M 1.90 M 2.90 M